We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-12.14%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$12.5B
AUM Growth
-$2.24B
Cap. Flow
-$357M
Cap. Flow %
-2.85%
Top 10 Hldgs %
31.17%
Holding
625
New
101
Increased
192
Reduced
179
Closed
101

Sector Composition

Rank Sector Weight
1 Technology 27.09%
2 Healthcare 17.88%
3 Financials 13.36%
4 Communication Services 10.87%
5 Consumer Discretionary 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.72T
$570M 4.55%
14,446,544
+2,230,320
+18% +$108M
MSFT icon
2
Microsoft
MSFT
$2.83T
$530M 4.23%
5,220,599
-344,525
-6% -$36.9M
ORCL icon
3
Oracle
ORCL
$346B
$473M 3.77%
10,466,640
-414,366
-4% -$19.9M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.89T
$456M 3.64%
8,800,200
+1,978,060
+29% +$106M
MMM icon
5
3M
MMM
$87.5B
$355M 2.84%
2,230,081
+928,404
+71% +$154M
MDT icon
6
Medtronic
MDT
$105B
$330M 2.63%
3,627,196
+146,896
+4% +$13.7M
JNJ icon
7
Johnson & Johnson
JNJ
$624B
$316M 2.52%
2,446,409
-188,034
-7% -$26.2M
COST icon
8
Costco
COST
$411B
$297M 2.37%
1,458,223
+62,291
+4% +$13.9M
UNH icon
9
UnitedHealth
UNH
$385B
$294M 2.35%
1,180,431
-390,189
-25% -$103M
WFC icon
10
Wells Fargo
WFC
$261B
$283M 2.26%
6,136,570
+1,142,338
+23% +$58.5M
ACN icon
11
Accenture
ACN
$84.9B
$274M 2.19%
1,943,097
-99,193
-5% -$15.7M
MRK icon
12
Merck
MRK
$322B
$271M 2.17%
3,719,920
-443,770
-11% -$31.3M
USB icon
13
US Bancorp
USB
$98.7B
$270M 2.16%
5,918,887
+870,213
+17% +$44.8M
AXP icon
14
American Express
AXP
$233B
$262M 2.1%
2,752,541
+95,958
+4% +$10M
TXN icon
15
Texas Instruments
TXN
$260B
$246M 1.96%
2,598,631
+882,009
+51% +$85.4M
ELV icon
16
Elevance Health
ELV
$82.3B
$244M 1.95%
927,937
-99,841
-10% -$27.5M
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$3.89T
$238M 1.9%
4,549,440
+15,320
+0.3% +$828K
RTX icon
18
RTX Corp
RTX
$282B
$224M 1.79%
3,341,035
+642,886
+24% +$50.4M
TJX icon
19
TJX Companies
TJX
$170B
$219M 1.75%
4,884,656
-291,394
-6% -$14.7M
CTSH icon
20
Cognizant
CTSH
$20.3B
$212M 1.69%
3,335,433
+121,648
+4% +$8.46M
CSCO icon
21
Cisco
CSCO
$444B
$209M 1.67%
4,818,464
-908,541
-16% -$41.6M
STLA icon
22
Stellantis
STLA
$16.7B
$182M 1.45%
12,569,607
-847,812
-6% -$13.7M
KO icon
23
Coca-Cola
KO
$349B
$176M 1.41%
3,726,927
+110,548
+3% +$5.29M
TSM icon
24
TSMC
TSM
$2.16T
$156M 1.24%
4,215,027
+842,100
+25% +$32.1M
RY icon
25
Royal Bank of Canada
RY
$290B
$152M 1.21%
2,220,835
+33,800
+2% +$2.47M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2018 Portfolio in Review

As of Q4 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 625 positions worth $12.5B, down 15% from $14.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2018 filing shows 101 new, 192 increased, 179 reduced and 101 closed positions. Its largest new stake was Booking.com: 1,992,850 shares worth $137M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $404M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2018 buy was Booking.com: 1,992,850 shares worth $137M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to 3M in Q4 2018, an estimated $154M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $404M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited iShares MSCI Taiwan ETF in Q4 2018, selling an estimated $160M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 31% of its $12.5B portfolio in Q4 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 101 new positions and closed 101 in Q4 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 15% quarter-over-quarter to $12.5B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2018, filed 13 Feb 2019.